W. Ray Kim, MD, MBA, FAASLD, currently serves as Professor of Medicine at Mayo Clinic Arizona, and previously served as Professor of Medicine and Chief, Division of Gastroenterology and Hepatology in the Department of Medicine at Stanford University. Dr. Kim received his MD degree from Seoul National University and his MBA from the University of Pennsylvania. He did his residency in internal medicine at the University of Arkansas, Little Rock followed by a fellowship in gastroenterology and advanced training in hematology/liver transplantation at Mayo Clinic.

Lisa VanWagner MD MSc FAST FAHA is Associate Professor of Medicine and Director of Clinical Research in the Division of Digestive and Liver Diseases at the University of Texas Southwestern Medical Center in Dallas, Texas. Her clinical research lab utilizes health services research methods to define and characterize cardiometabolic disease risk prediction, prevention, and treatment approaches in patients with chronic liver disease particularly surrounding liver transplantation. She has published over 150 peer-reviewed manuscripts and received continuous NIH funding since 2012. Dr.

Dr. Serper is Associate Professor of Medicine at the University of Pennsylvania. She is a transplant hepatologist with expertise in epidemiology, health services research, patient-oriented research and digital health. Her research works studying clinical outcomes in cirrhosis and designing interventions to improve health outcomes of patients with chronic advanced liver disease, alcohol-associated liver disease, and liver transplantation.

I am a Transplant Hepatologist and Associate Clinical Professor at UCSF. I am the Director of our Liver Cancer Multidisciplinary Program as well as the Medical Director of our Live Donor Liver Transplantation program. My research focus is primarily on selection criteria and liver transplant outcomes for patients with HCC including with respect to down-staging, incorporation of biomarkers, and improving transplant access.

Dr. Taner is a Professor of Surgery and Consultant in Immunology at Mayo Clinic, Rochester. He is the Chair of the Division of Transplantation Surgery, and the surgical director of liver transplantation of both the adult and pediatric programs at the same institution. His clinical practice involves liver transplantation, living donor hepatectomies and nephrectomies. His research focuses on liver transplant immunobiology, investigating the interaction between the liver allografts and the host immune responses. He is the current co-Editor-in-Chief of Liver Transplantation.

Dr. Cárdenas is a Staff Member and Consultant of the Institute of Digestive Diseases and Metabolism at Hospital Clinic and Accredited Professor of Medicine (Catalan Agency for Quality Assessment) with the University of Barcelona. He pursued his Residency and Fellowship in Internal Medicine, Gastroenterology, Hepatology at Boston University and Harvard Medical School at Beth Israel Deaconess Medical Center in Boston. Dr. Cardenas is Board Certified in Internal Medicine, Gastroenterology and Hepatology by the American Board of Internal Medicine.

Dr. Sonal Kumar graduated summa cum laude from Washington University in St. Louis in 2002 and obtained her medical degree in 2006 from Washington University School of Medicine. She subsequently completed internal medicine residency at Barnes-Jewish Hospital - Washington University School of Medicine and then Gastroenterology and Hepatology fellowship at Brigham and Women's Hospital - Harvard University. During fellowship, she also received her Master of Public Health from the Harvard School of Public Health.

Dr. Tincopa completed her medical degree and residency in internal medicine at Johns Hopkins University. She completed gastroenterology and transplant hepatology fellowship at the University of Michigan. Dr. Tincopa has a Masters degree in Health and Healthcare Research from the University of Michigan and is also board certified in Obesity Medicine.

Dr. Gawrieh is Professor of Medicine at Indiana University School of Medicine. His research investigates the genetic and environmental modifiers, diagnostics and therapeutics of metabolic dysfunction- and alcohol-associated steatotic liver disease.

Arun J. Sanyal, M.D., is a Professor of Medicine, Physiology, and Molecular Pathology in the Division of Gastroenterology at Virginia Commonwealth University (VCU) Medical Center in Richmond, Virginia. At VCU, he is currently the Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. He is ranked in the top 0.1% of all biomedical scientists by Stanford University rankings. Dr. Sanyal serves as Chairman of the NIH NASH Clinical Research Network, the NIMBLE and MASH track projects of FNIH, and the Liver Forum for NASH and fibrosis.